SlideShare uma empresa Scribd logo
1 de 14
Pharmacokinetics
Distribution
Dr. S. Parasuraman
Associate Professor, Faculty of Pharmacy,
AIMST University, Malaysia.
Academic session: Mar. - Jul. 2022 (FoP) 2
Pharmacokinetics - distribution
• Drug distribution
reversibly leaves
is the process by which a drug
the bloodstreamand enters the
interstitium (extracellular fluid) and the tissues.
• Movement of drug proceeds until an equilibrium is
established between unbound drug in the plasma and
the tissue fluids.
Pharmacokinetics - distribution
• Apparent volume of distribution (V).
• Presuming that the body behaves as a single
homogeneous compartment with volume V into which
the drug gets immediately and uniformly distributed.
Academic session: Mar. - Jul. 2022 (FoP) 3
Academic session: Mar. - Jul. 2022 (FoP) 4
Pharmacokinetics - distribution
• Apparent volume of distribution (V).
Calculation:
• A 58 kg male patient is given 350 milligrams of Drug B,
which distributes throughout extracellular fluid, but not
readily into tissues. On measuring a peak level, we may
get a value of 20 milligrams per litter. Calculate the
apparent volume of distribution per Kg body weight.
= 350/20
= 17.5 litter of plasma
= 17.5/58
= 0.30 litter/ kg
Academic session: Mar. - Jul. 2022 (FoP) 5
Pharmacokinetics - distribution
• The distribution of a drug from the plasma to the
interstitium depends on
A. Cardiac output and local blood flow
B. capillary permeability
C. Binding of drugs to plasma proteins and tissues
D. Lipophilicity
E. Volume of distribution
Academic session: Mar. - Jul. 2022 (FoP) 6
Distribution of a drug depends on
A. Cardiac output and local blood flow
– The rate of blood flow to the tissue capillaries varies
widely.
– Blood flow to “vessel-rich organs” (brain, liver, and kidney)
is greater than that to the skeletal muscles.
– High blood flow, together with high lipophilicity permits
rapid distribution
Academic session: Mar. - Jul. 2022 (FoP) 7
Distribution of a drug depends on
B. Capillary permeability
– Capillary permeability is determined by capillary structure
and by the chemical nature of the drug. Capillary structure
varies in terms of the fraction of the basement membrane
exposed by slit junctions between endothelial cells.
– In the liver and spleen, a significant portion of the
basement
discontinuous capillaries through which large
membrane is exposed due to large,
plasma
proteins can pass. In the brain, the capillary structure is
continuous, and there are no slit junctions. To enter the
brain, drugs must pass through the endothelial cells of the
CNS capillaries or undergo active transport.
Distribution of a drug depends on
B. Capillary permeability
Academic session: Mar. - Jul. 2022 (FoP) 8
Academic session: Mar. - Jul. 2022 (FoP) 9
Distribution of a drug depends on
C. Binding of drugs to plasma proteins and tissues
– Binding to plasma proteins: Reversible binding to plasma
proteins sequesters drugs in a nondiffusible form and
slows transfer out of the vascular compartment. Many
drugs reversibly bind to albumin, 1-acid glycoprotein, or
other proteins in plasma. Albumin is the major drug-
binding protein, and it may act as a drug reservoir. Drug
bound to albumin is not filtered by renal glomerulus but
may be cleared by the proximal renal tubule and liver.
– The extent of binding to proteins is dependent on several
factors such as affinity, number of binding sites, and drug
concentrations at the site.
Academic session: Mar. - Jul. 2022 (FoP) 10
Distribution of a drug depends on
C. Binding of drugs to plasma proteins and tissues
– Binding to tissue proteins: Many drugs accumulate in
tissues, leading to higher concentrations in tissues than in
interstitial fluid and blood. Drugs may accumulate because
of binding to lipids, proteins, or nucleic acids. Drugs may
also undergo active transport into tissues. Tissue reservoirs
may serve as a major source of the drug and prolong its
actions or cause local drug toxicity.
Academic session: Mar. - Jul. 2022 (FoP) 11
Distribution of a drug depends on
D. Lipophilicity:
– The chemical nature of a drug strongly influences its ability
to cross cell membranes. Lipophilic drugs readily move
across most biologic membranes. By contrast, hydrophilic
drugs do not readily penetrate cell membranes and must
pass through slit junctions.
Distribution of a drug depends on
E. Volume of distribution
– The apparent volume of distribution (Vd) is defined as the
fluid volume that is required to contain the entire drug in
the body at the same concentration measured in the
plasma. It is calculated by dividing the dose that ultimately
gets into the systemic circulation by the plasma
concentration at time zero (C0).
Academic session: Mar. - Jul. 2022 (FoP) 12
Academic session: Sep. 2018 - Jan. 2019
(BPT)
13
Distribution of a drug depends on
E. Volume of distribution calculation:
• 64-year-old female patient (70 kg) was recently
diagnosed with gram-positive pathogenic infection. He
received 2000 mg of vancomycin as an IV loading dose.
The peak plasma concentration of vancomycin was
reported to be 28.5 mg/L. The apparent volume of
distribution is:
= Amount of drug/ Plasma concentration
= 2000/28.5
= 70.2 L for 70 kg
= 1 L/ kg
Academic session: Sep. 2018 - Jan. 2019
(BPT)
14

Mais conteúdo relacionado

Mais procurados

Drug Distribution.ppt
Drug Distribution.pptDrug Distribution.ppt
Drug Distribution.pptFarazaJaved
 
Physiological pharmacokinetic models
Physiological pharmacokinetic modelsPhysiological pharmacokinetic models
Physiological pharmacokinetic modelsSanjay Yadav
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolismDr. Ramesh Bhandari
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionAreej Abu Hanieh
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
 
Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability Anindya Jana
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationpavithra vinayak
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing intervalDr. Ramesh Bhandari
 
PHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTION
PHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTIONPHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTION
PHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTIONAffrin Shaik
 
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)N Anusha
 

Mais procurados (20)

Drug distribution
Drug distributionDrug distribution
Drug distribution
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
 
Bioavailability
BioavailabilityBioavailability
Bioavailability
 
Bioavailability and Bioequivalence
Bioavailability and BioequivalenceBioavailability and Bioequivalence
Bioavailability and Bioequivalence
 
Distribution
DistributionDistribution
Distribution
 
Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
Drug Distribution.ppt
Drug Distribution.pptDrug Distribution.ppt
Drug Distribution.ppt
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Physiological pharmacokinetic models
Physiological pharmacokinetic modelsPhysiological pharmacokinetic models
Physiological pharmacokinetic models
 
Bioavailability testing protocol
Bioavailability testing protocolBioavailability testing protocol
Bioavailability testing protocol
 
Absorption of drug
Absorption of drugAbsorption of drug
Absorption of drug
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolism
 
Pharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorptionPharmacokinetics / Biopharmaceutics - drug absorption
Pharmacokinetics / Biopharmaceutics - drug absorption
 
Biopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug AbsorptionBiopharmaceutics: Mechanisms of Drug Absorption
Biopharmaceutics: Mechanisms of Drug Absorption
 
Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability Methods For Assesment Of Bioavailability
Methods For Assesment Of Bioavailability
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
PHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTION
PHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTIONPHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTION
PHYSICOCHEMICAL FACTORS AFFECTING DRUG ABSORPTION
 
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
 

Semelhante a Distribution

Distribution of Drug
Distribution of DrugDistribution of Drug
Distribution of DrugSHUBHAMGWAGH
 
Factors affecting distribution of drug
Factors affecting distribution of drugFactors affecting distribution of drug
Factors affecting distribution of drugDr. SHUBHRAJIT MANTRY
 
Tumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliveryTumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliverySHUBHAMGWAGH
 
Drug distribution and factors affecting drug distribution
Drug distribution and factors affecting drug distributionDrug distribution and factors affecting drug distribution
Drug distribution and factors affecting drug distributionLuqmanIbniYaseen
 
Drug distribution
Drug distribution Drug distribution
Drug distribution Faisal Shah
 
Drug distribution
Drug distribution Drug distribution
Drug distribution Faisal Shah
 
distribution.pdf
distribution.pdfdistribution.pdf
distribution.pdfEducation
 
Barriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptxBarriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptxMeghajoshi86
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugsDipak Bari
 
Drug distribution and protein binding
Drug distribution and protein bindingDrug distribution and protein binding
Drug distribution and protein bindingAnjali9410
 
Distribution edited
Distribution editedDistribution edited
Distribution editedmizan00
 

Semelhante a Distribution (20)

Distribution of Drug
Distribution of DrugDistribution of Drug
Distribution of Drug
 
DISTRIBUTION OF DRUGS
DISTRIBUTION OF DRUGSDISTRIBUTION OF DRUGS
DISTRIBUTION OF DRUGS
 
Factors affecting distribution of drug
Factors affecting distribution of drugFactors affecting distribution of drug
Factors affecting distribution of drug
 
Distribution.pptx
Distribution.pptxDistribution.pptx
Distribution.pptx
 
Brain targeting
Brain targetingBrain targeting
Brain targeting
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
 
Tumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug deliveryTumour targeting and Brain specific drug delivery
Tumour targeting and Brain specific drug delivery
 
Drug distribution and factors affecting drug distribution
Drug distribution and factors affecting drug distributionDrug distribution and factors affecting drug distribution
Drug distribution and factors affecting drug distribution
 
Drug Distribution
Drug DistributionDrug Distribution
Drug Distribution
 
Drug distribution
Drug distribution Drug distribution
Drug distribution
 
Drug distribution
Drug distribution Drug distribution
Drug distribution
 
distribution.pdf
distribution.pdfdistribution.pdf
distribution.pdf
 
Barriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptxBarriers to protein and peptide delivery.pptx
Barriers to protein and peptide delivery.pptx
 
DISTRIBUTION OF DRUG
DISTRIBUTION OF DRUGDISTRIBUTION OF DRUG
DISTRIBUTION OF DRUG
 
Absorption
AbsorptionAbsorption
Absorption
 
Distribution of drugs
Distribution of drugsDistribution of drugs
Distribution of drugs
 
Drug distribution and protein binding
Drug distribution and protein bindingDrug distribution and protein binding
Drug distribution and protein binding
 
4_DISTRIBUTION.pptx
4_DISTRIBUTION.pptx4_DISTRIBUTION.pptx
4_DISTRIBUTION.pptx
 
Distribution edited
Distribution editedDistribution edited
Distribution edited
 
distribution of drugs
distribution of drugsdistribution of drugs
distribution of drugs
 

Mais de Subramani Parasuraman

Introduction to pharmacology (For Allied health students)
Introduction to pharmacology (For Allied health students)Introduction to pharmacology (For Allied health students)
Introduction to pharmacology (For Allied health students)Subramani Parasuraman
 
Pharmacodynamics - Introduction (Allied health students)
Pharmacodynamics - Introduction (Allied health students)Pharmacodynamics - Introduction (Allied health students)
Pharmacodynamics - Introduction (Allied health students)Subramani Parasuraman
 
Research with animals and animal models.pptx
Research with animals and animal models.pptxResearch with animals and animal models.pptx
Research with animals and animal models.pptxSubramani Parasuraman
 
Cerebellum and control of postures and movements.pptx
Cerebellum and control of postures and movements.pptxCerebellum and control of postures and movements.pptx
Cerebellum and control of postures and movements.pptxSubramani Parasuraman
 
Drugs used in haematological disorders
Drugs used in haematological disordersDrugs used in haematological disorders
Drugs used in haematological disordersSubramani Parasuraman
 

Mais de Subramani Parasuraman (20)

Introduction to pharmacology (For Allied health students)
Introduction to pharmacology (For Allied health students)Introduction to pharmacology (For Allied health students)
Introduction to pharmacology (For Allied health students)
 
Pharmacodynamics - Introduction (Allied health students)
Pharmacodynamics - Introduction (Allied health students)Pharmacodynamics - Introduction (Allied health students)
Pharmacodynamics - Introduction (Allied health students)
 
Research with animals and animal models.pptx
Research with animals and animal models.pptxResearch with animals and animal models.pptx
Research with animals and animal models.pptx
 
Nicotine and Tobacco
Nicotine and TobaccoNicotine and Tobacco
Nicotine and Tobacco
 
Statistical software.pptx
Statistical software.pptxStatistical software.pptx
Statistical software.pptx
 
Cerebellum and control of postures and movements.pptx
Cerebellum and control of postures and movements.pptxCerebellum and control of postures and movements.pptx
Cerebellum and control of postures and movements.pptx
 
Drugs Used in Renal Alteration
Drugs Used in Renal AlterationDrugs Used in Renal Alteration
Drugs Used in Renal Alteration
 
Drugs Used in Endocrine Alteration
Drugs Used in Endocrine AlterationDrugs Used in Endocrine Alteration
Drugs Used in Endocrine Alteration
 
Antidiabetic drugs
Antidiabetic drugsAntidiabetic drugs
Antidiabetic drugs
 
Pancreatic Hormones
Pancreatic HormonesPancreatic Hormones
Pancreatic Hormones
 
Terrestrial laboratory animals
Terrestrial laboratory animalsTerrestrial laboratory animals
Terrestrial laboratory animals
 
Drugs used in haematological disorders
Drugs used in haematological disordersDrugs used in haematological disorders
Drugs used in haematological disorders
 
Laboratory animals
Laboratory animalsLaboratory animals
Laboratory animals
 
Immunomodulators-1.pptx
Immunomodulators-1.pptxImmunomodulators-1.pptx
Immunomodulators-1.pptx
 
Immunomodulators - 3.pptx
Immunomodulators - 3.pptxImmunomodulators - 3.pptx
Immunomodulators - 3.pptx
 
Immunomodulators - 2.pptx
Immunomodulators - 2.pptxImmunomodulators - 2.pptx
Immunomodulators - 2.pptx
 
Acetylcholine bioassay
 Acetylcholine bioassay Acetylcholine bioassay
Acetylcholine bioassay
 
Oxytocin bioassay
Oxytocin bioassayOxytocin bioassay
Oxytocin bioassay
 
Type of bioassays
Type of bioassaysType of bioassays
Type of bioassays
 
Principles of bioassay
Principles of bioassayPrinciples of bioassay
Principles of bioassay
 

Último

Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 

Último (20)

Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 

Distribution

  • 1. Pharmacokinetics Distribution Dr. S. Parasuraman Associate Professor, Faculty of Pharmacy, AIMST University, Malaysia.
  • 2. Academic session: Mar. - Jul. 2022 (FoP) 2 Pharmacokinetics - distribution • Drug distribution reversibly leaves is the process by which a drug the bloodstreamand enters the interstitium (extracellular fluid) and the tissues. • Movement of drug proceeds until an equilibrium is established between unbound drug in the plasma and the tissue fluids.
  • 3. Pharmacokinetics - distribution • Apparent volume of distribution (V). • Presuming that the body behaves as a single homogeneous compartment with volume V into which the drug gets immediately and uniformly distributed. Academic session: Mar. - Jul. 2022 (FoP) 3
  • 4. Academic session: Mar. - Jul. 2022 (FoP) 4 Pharmacokinetics - distribution • Apparent volume of distribution (V). Calculation: • A 58 kg male patient is given 350 milligrams of Drug B, which distributes throughout extracellular fluid, but not readily into tissues. On measuring a peak level, we may get a value of 20 milligrams per litter. Calculate the apparent volume of distribution per Kg body weight. = 350/20 = 17.5 litter of plasma = 17.5/58 = 0.30 litter/ kg
  • 5. Academic session: Mar. - Jul. 2022 (FoP) 5 Pharmacokinetics - distribution • The distribution of a drug from the plasma to the interstitium depends on A. Cardiac output and local blood flow B. capillary permeability C. Binding of drugs to plasma proteins and tissues D. Lipophilicity E. Volume of distribution
  • 6. Academic session: Mar. - Jul. 2022 (FoP) 6 Distribution of a drug depends on A. Cardiac output and local blood flow – The rate of blood flow to the tissue capillaries varies widely. – Blood flow to “vessel-rich organs” (brain, liver, and kidney) is greater than that to the skeletal muscles. – High blood flow, together with high lipophilicity permits rapid distribution
  • 7. Academic session: Mar. - Jul. 2022 (FoP) 7 Distribution of a drug depends on B. Capillary permeability – Capillary permeability is determined by capillary structure and by the chemical nature of the drug. Capillary structure varies in terms of the fraction of the basement membrane exposed by slit junctions between endothelial cells. – In the liver and spleen, a significant portion of the basement discontinuous capillaries through which large membrane is exposed due to large, plasma proteins can pass. In the brain, the capillary structure is continuous, and there are no slit junctions. To enter the brain, drugs must pass through the endothelial cells of the CNS capillaries or undergo active transport.
  • 8. Distribution of a drug depends on B. Capillary permeability Academic session: Mar. - Jul. 2022 (FoP) 8
  • 9. Academic session: Mar. - Jul. 2022 (FoP) 9 Distribution of a drug depends on C. Binding of drugs to plasma proteins and tissues – Binding to plasma proteins: Reversible binding to plasma proteins sequesters drugs in a nondiffusible form and slows transfer out of the vascular compartment. Many drugs reversibly bind to albumin, 1-acid glycoprotein, or other proteins in plasma. Albumin is the major drug- binding protein, and it may act as a drug reservoir. Drug bound to albumin is not filtered by renal glomerulus but may be cleared by the proximal renal tubule and liver. – The extent of binding to proteins is dependent on several factors such as affinity, number of binding sites, and drug concentrations at the site.
  • 10. Academic session: Mar. - Jul. 2022 (FoP) 10 Distribution of a drug depends on C. Binding of drugs to plasma proteins and tissues – Binding to tissue proteins: Many drugs accumulate in tissues, leading to higher concentrations in tissues than in interstitial fluid and blood. Drugs may accumulate because of binding to lipids, proteins, or nucleic acids. Drugs may also undergo active transport into tissues. Tissue reservoirs may serve as a major source of the drug and prolong its actions or cause local drug toxicity.
  • 11. Academic session: Mar. - Jul. 2022 (FoP) 11 Distribution of a drug depends on D. Lipophilicity: – The chemical nature of a drug strongly influences its ability to cross cell membranes. Lipophilic drugs readily move across most biologic membranes. By contrast, hydrophilic drugs do not readily penetrate cell membranes and must pass through slit junctions.
  • 12. Distribution of a drug depends on E. Volume of distribution – The apparent volume of distribution (Vd) is defined as the fluid volume that is required to contain the entire drug in the body at the same concentration measured in the plasma. It is calculated by dividing the dose that ultimately gets into the systemic circulation by the plasma concentration at time zero (C0). Academic session: Mar. - Jul. 2022 (FoP) 12
  • 13. Academic session: Sep. 2018 - Jan. 2019 (BPT) 13 Distribution of a drug depends on E. Volume of distribution calculation: • 64-year-old female patient (70 kg) was recently diagnosed with gram-positive pathogenic infection. He received 2000 mg of vancomycin as an IV loading dose. The peak plasma concentration of vancomycin was reported to be 28.5 mg/L. The apparent volume of distribution is: = Amount of drug/ Plasma concentration = 2000/28.5 = 70.2 L for 70 kg = 1 L/ kg
  • 14. Academic session: Sep. 2018 - Jan. 2019 (BPT) 14